
Bajra Pharma Private Limited
Pharmaceutical company providing financial services and products for human and animal healthcare.
Pharmaceutical company providing financial services and products for human and animal healthcare.
Delhi, India
+91-XXXXXXXXXX
U24231DL2003PTC122861
122861
Private Limited Indian Non-Government Company
30 Oct 2003
18 Nov 2020
31 Mar 2020
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Pramod Basotia ![]() | Director | 06-Mar-2012 | Current |
Ashok Sharma ![]() | Director | 30-Oct-2003 | Current |
Bajra Pharma Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 45.36% increase. The company also saw a substantial improvement in profitability, with a 25.41% increase in profit. The company's net worth moved up by a moderate rise of 0.07%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2019, Bajra Pharma had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Pramod Basotia and Ashok Sharma are mutual person
Pramod Basotia and Ashok Sharma are mutual person
Pramod Basotia and Ashok Sharma are mutual person
Ashok Sharma is a mutual person
Ashok Sharma is a mutual person
Ashok Sharma is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Bajra Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Bajra Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bajra Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Bajra Pharma Private Limited last Annual general meeting of members was held on 18 Nov 2020 as per latest MCA records.
Bajra Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Delhi.
Pramod Kumar Basotia was appointed as a Director was appointed as a Director on 06 Mar 2012 & has been associated with this company since 13 years 23 days .
Ashok Kumar Sharma was appointed as a Director was appointed as a Director on 30 Oct 2003 & has been associated with this company since 21 years 5 months .
Bajra Pharma Private Limited was registered on 30 Oct 2003 with Roc Delhi & aged 21 years 5 months as per MCA records.
Bajra Pharma Private Limited was incorporated on 30 Oct 2003.
The authorized share capital of Bajra Pharma Private Limited is ₹ 1.00 M and paid-up capital is ₹ 1.00 M.
Currently 2 directors are associated with Bajra Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Bajra Pharma Private Limited is Shop No 18 Csc-3, Sector 2 India, Rohini, Delhi, 110085.
The corporate identification number (CIN) of Bajra Pharma Private Limited is U24231DL2003PTC122861 and the company number is 122861 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2019, the revenue trend for Bajra Pharma Private Limited has risen by 45.36%.
The financial reports for the fiscal year 2019 indicates that The net worth of Bajra Pharma Private Limited has experienced an upsurge of 0.07%.
The most recent Balance Sheet for Bajra Pharma Private Limited was filed with the ROC on 31 Mar 2020.
DS